4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004526
Chief Scientific Officer sold 7,540 shares at $25.50 ($192,270)
- Chief Scientific Officer acquired 7,540 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zago Wagner M. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-18 | Exercise or conversion : show line 1 in the form | +7,540 | $6.41 | $48,331 | 7,540 | D |
| 2021-02-18 | Sale : show line 2 in the form | −7,540 | $25.50 | $192,270 | 0 | D |
| Open-market sales · 7,540 sh · avg $25.50 · $192,270 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-18 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,540 | $6.41 | 2023-01-29 | 7,540 | 0 | D |
Loading xslF345X03/doc1.xml…